TIPE2 mRNA overexpression correlates with TNM staging in renal cell carcinoma tissues

Zhang,Zongliang; Qi,Haiyan; Hou,Sichuan; Jin,Xunbo

doi:10.3892/ol.2013.1388

TIPE2 mRNA overexpression correlates with TNM staging in renal cell carcinoma tissues

Authors:
- Zongliang Zhang
- Haiyan Qi
- Sichuan Hou
- Xunbo Jin
View Affiliations

Affiliations: School of Medicine, Shandong University, Jinan, Shandong 250012, P.R. China, Department of Urology, Qingdao Municipal Hospital, Qingdao, Shandong 266071, P.R. China
Published online on: June 10, 2013 https://doi.org/10.3892/ol.2013.1388
Pages: 571-575

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tumor necrosis factor a-induced protein-8 like-2 (TIPE2) is a gene that maintains immune homeostasis. The aim of the present study was to determine whether TIPE2 is associated with renal cell carcinoma (RCC) progression. The mRNA expression levels of TIPE2 and myxoma resistance protein 1 (MX1; a type I interferon-inducible gene) were investigated in renal cancer tissues. A total of 46 patients who fulfilled the RCC criteria of the World Health Organization (WHO; revised in 2004) and 39 control patients with renal contusions requiring surgical extraction were enrolled. Tumor and normal renal tissues were sampled from all subjects through surgery. Total RNA was extracted and the expression of the TIPE2 and MX1 genes was evaluated by quantitative polymerase chain reaction (qPCR) analysis. TIPE2 mRNA expression was significantly upregulated in the RCC patients compared with the controls (P=0.001), while MX1 mRNA expression was decreased in the RCC patients compared with the controls (P=0.0001). Furthermore, the TIPE2 mRNA expression levels were positively correlated with TNM staging (r=0.803, P=0.001) and showed a negative correlation with the MX1 mRNA expression levels (r=-0.763, P=0.001) in the RCC patients. These results indicate that the increased expression of the TIPE2 gene is markedly associated with RCC and suggests an important role for the TIPE2 gene in the pathogenesis of RCC.

View Figures

View References

1.	Ku JH, Park YH, Myung JK, Moon KC, Kwak C and Kim HH: Expression of hypoxia inducible factor-1α and 2α in conventional renal cell carcinoma with or without sarcomatoid differentiation. Urol Oncol. 29:731–737. 2011.
2.	Cavalcanti E, Gigante M, Mancini V, et al: JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8 T cells in renal cell carcinoma patients. J Biomed Biotechnol. 2010:9357642010. View Article : Google Scholar : PubMed/NCBI
3.	Atkins D, Ferrone S, Schmahl GE, et al: Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma? J Urol. 171:885–889. 2004. View Article : Google Scholar : PubMed/NCBI
4.	Li D, Song L, Fan Y, et al: Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Immunol. 133:422–427. 2009. View Article : Google Scholar : PubMed/NCBI
5.	Sun H, Gong S, Carmody RJ, et al: TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell. 133:415–426. 2008. View Article : Google Scholar : PubMed/NCBI
6.	Luan YY, Yao YM, Zhang L, et al: Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice. Mol Immunol. 49:219–226. 2011.
7.	Kumar D, Whiteside TL and Kasid U: Identification of a novel tumor necrosis factor-alpha-inducible gene SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin-1 beta-converting enzyme-inhibitory protein. J Biol Chem. 275:2973–2978. 2000. View Article : Google Scholar
8.	Horrevoets AJ, Fontijn RD, van Zonneveld AJ, de Vries CJ, ten Cate JW and Pannekoek H: Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes. Blood. 93:3418–3431. 1999.
9.	You Z, Ouyang H, Lopatin D, Polver PJ and Wang CY: Nuclear factor-kappa B inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity. J Biol Chem. 276:26398–26404. 2001. View Article : Google Scholar
10.	Zhang HG, Hyde K, Page GP, et al: Novel tumor necrosis factor alpha-regulated genes in rheumatoid arthritis. Arthritis Rheum. 50:420–431. 2004. View Article : Google Scholar : PubMed/NCBI
11.	Zhang S, Zhang Y, Wei X, et al: Expression and regulation of a novel identified TNFAIP8 family is associated with diabetic nephropathy. Biochim Biophys Acta. 1802:1078–1086. 2010. View Article : Google Scholar : PubMed/NCBI
12.	Zhang C, Chakravarty D, Sakabe I, et al: Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol Ther. 13:947–955. 2006. View Article : Google Scholar : PubMed/NCBI
13.	Lee PY, Li Y, Richards HB, et al: Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis Rheum. 56:3759–3769. 2007. View Article : Google Scholar : PubMed/NCBI
14.	Ebele JN, Sauter G, Epstein JI and Sesterhenn IA: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC; Lyon: 2004
15.	Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A III: AJCC Cancer Staging Manual. 2010, 7th edition. Springer; New York:
16.	Kumar D, Gokhale P, Broustas C, Chakravarty D, Ahmad I and Kasid U: Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells. Oncogene. 23:612–616. 2004. View Article : Google Scholar : PubMed/NCBI
17.	Patel S, Wang FH, Whiteside TL and Kasid U: Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: implications in metastasis and/or radiation response. Oral Oncol. 33:197–203. 1997. View Article : Google Scholar
18.	Yoshinaga-Hirabayashi T and Yoneda Y: Expression of SCC in ovarian granulosa cells and cultured cells, induced rapid structural changes in mitochondria. Ital J Anat Embryol. 106(2 Suppl 1): 51–57. 2001.PubMed/NCBI
19.	Dong QZ, Zhao Y, Liu Y, Wang Y, et al: Overexpression of SCC-S2 correlates with lymph node metastasis and poor prognosis in patients with non-small-cell lung cancer. Cancer Sci. 101:1562–1569. 2010. View Article : Google Scholar : PubMed/NCBI
20.	Zhang X, Wang J, Fan C, et al: Crystal structure of TIPE2 provides insights into immune homeostasis. Nat Struct Mol Biol. 16:89–90. 2009. View Article : Google Scholar : PubMed/NCBI
21.	Gus-Brautbar Y, Johnson D, Zhang L, et al: The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras. Mol Cell. 45:610–618. 2012. View Article : Google Scholar : PubMed/NCBI
22.	Stark GR, Kerr IM, Williams BR, Silverman RH and Schreiber RD: How cells respond to interferons. Annu Rev Biochem. 67:227–264. 1998. View Article : Google Scholar : PubMed/NCBI
23.	Pascual V, Farkas L and Banchereau J: Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol. 18:676–682. 2006. View Article : Google Scholar : PubMed/NCBI
24.	Koutouzov S, Mathian A and Dalloul A: Type-I interferons and systemic lupus erythematosus. Autoimmun Rev. 5:554–562. 2006. View Article : Google Scholar : PubMed/NCBI
25.	Hawiger D, Inaba K, Dorsett Y, et al: Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med. 194:769–779. 2001. View Article : Google Scholar : PubMed/NCBI
26.	Feng X, Wu H, Grossman JM, et al: Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum. 54:2951–2962. 2006. View Article : Google Scholar : PubMed/NCBI
27.	Zhuang H, Narain S, Sobel E, et al: Association of anti-nucleoprotein autoantibodies with upregulation of Type I interferon-inducible gene transcripts and dendritic cell maturation in systemic lupus erythematosus. Clin Immunol. 117:238–250. 2005. View Article : Google Scholar : PubMed/NCBI
28.	Colonna M: TLR pathways and IFN-regulatory factors: to each its own. Eur J Immunol. 37:306–309. 2007. View Article : Google Scholar : PubMed/NCBI
29.	Honda K, Yanai H, Negishi H, et al: IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 434:772–777. 2005. View Article : Google Scholar : PubMed/NCBI
30.	Lacunza E, Baudis M, Colussi AG, Segal-Eiras A, Croce MV and Abba MC: MUC1 oncogene amplification correlates with protein overexpression in invasive breast carcinoma cells. Cancer Genet Cytogenet. 201:102–110. 2010. View Article : Google Scholar : PubMed/NCBI